Form 4: Klaviyo Director Plans Stock Sale Under 10b5-1 Plan
Insider Transaction Report
Klaviyo Director Susan St. Ledger filed a Form 4 indicating a planned sale of 3,413 shares of Series A Common Stock on September 10, 2025, under a 10b5-1 trading plan.
Summary
- Director Susan St. Ledger reported a planned sale of 3,413 shares of Klaviyo, Inc. Series A Common Stock.
- The transaction is scheduled for September 10, 2025, at a price of $32.2 per share.
- This sale is being conducted pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2025.
- Following the planned transaction, Ms. St. Ledger will beneficially own 10,939 shares, comprising 5,119 shares of Series A Common Stock and 5,820 unvested restricted stock units (RSUs).
Sentiment
Score: 5
Explanation: The filing reports a planned insider stock sale under a Rule 10b5-1 trading plan. While insider selling can sometimes be viewed negatively, the pre-scheduled nature of a 10b5-1 plan mitigates concerns about discretionary timing based on non-public information. It's a routine disclosure for executive liquidity management.
Positives
- The transaction is being executed under a Rule 10b5-1 trading plan, which provides transparency and indicates the sale was pre-scheduled and not based on recent non-public information.
Negatives
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces insider ownership, though the impact is often mitigated by the pre-planned nature.
Future Outlook
This Form 4 reports a planned insider transaction and does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This filing pertains to an individual insider transaction, which is a routine aspect of executive compensation and personal financial planning. It does not directly reflect broader industry trends or competitive dynamics, but rather the liquidity management of a company director.
Stakeholder Impact
- Shareholders: May view the insider sale with slight caution, though the 10b5-1 plan provides transparency. The impact is likely minimal given the relatively small number of shares compared to total outstanding.
Next Steps
- The planned sale of 3,413 shares of Series A Common Stock is scheduled to occur on September 10, 2025.
Key Dates
| Date | Description |
|---|---|
| 06/11/2025 | Date Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 09/10/2025 | Date of planned transaction for the sale of Series A Common Stock. |
| 09/12/2025 | Date the Form 4 was signed by the Attorney-in-Fact. |
Recommendation
holdThe filing details a pre-scheduled insider stock sale under a 10b5-1 plan, which is a routine event for executive liquidity management and does not typically signal a change in the company's fundamental outlook. While insider selling can sometimes be a minor negative signal, the planned nature of this transaction reduces its significance. Therefore, the filing itself does not provide a strong basis for a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this information.
Keywords
Klaviyo, KVYO, Insider Trading, Form 4, Stock Sale, Director, 10b5-1 Plan, Equity, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.